Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation.
The ability of probucol, a lipid-lowering drug with antioxidant properties, to prevent the Cu2+-induced oxidation of human plasma low density lipoproteins (LDL) was examined as a function of the concentration of probucol in LDL. In the absence of probucol, 3 microM Cu2+ induced half-maximal LDL lipi...
Main Authors: | R L Barnhart, S J Busch, R L Jackson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1989-11-01
|
Series: | Journal of Lipid Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520382195 |
Similar Items
-
Probucol alleviates atherosclerosis and improves high density lipoprotein function
by: Zhong Jian-Kai, et al.
Published: (2011-11-01) -
Influence of probucol on cholesterol and lipoprotein metabolism in man.
by: Y A Kesäniemi, et al.
Published: (1984-08-01) -
Inhibition of low density lipoprotein oxidation by thyronines, probucol, ascorbate and ACI-reductones /
by: Hanna, Atef Nagib
Published: (1993) -
The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteins.
by: R F Atmeh, et al.
Published: (1983-05-01) -
Interaction of Antioxidants Probucol and Caffeic Acid Phenethyl Ester with Phosphatidylcholine Liposomes and Human Low Density Lipoprotein
by: Lin, Hua-Jin, et al.
Published: (1994)